Bayer announces start of Phase 2 GenePHIT trial for AB-1002

Pallavi Madhiraju- February 17, 2024 0

Bayer AG and its subsidiary Asklepios BioPharmaceutical, Inc. (AskBio), have achieved a significant milestone in the fight against congestive heart failure (CHF) with the randomization ... Read More

Bayer to acquire Asklepios BioPharmaceutical in $4bn deal: A strategic move in gene therapy innovation

pharmanewsdaily- October 26, 2020 0

In a significant development within the pharmaceutical industry, German pharma giant Bayer has reached an agreement to acquire the US-based clinical-stage gene therapy company Asklepios ... Read More